Skip to content

Alumis Inc. ALMS Shares (Diluted)

Shares (Diluted) at other companies

Amgen logo
AmgenAMGN
544M+0.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
21.5M+7.5%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
66.6M+0.3%
Immunome logo
ImmunomeIMNM
113.1M+42.5%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
24.7M+75.9%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
137.6M-3.9%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s shares (diluted)?
Alumis Inc. (ALMS) reported shares (diluted) of 125.1M in Q1 2026.
How has Alumis Inc.'s shares (diluted) changed year-over-year?
Alumis Inc.'s shares (diluted) increased by 130.4% year-over-year, from 54.3M to 125.1M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.